In addition, the rate of tumour growth was markedly decreased when LPS-treated tumour-bearing mice were administered DNase I or a p38 MAPK signalling pathway inhibitor, which can inhibit the formation of NETs ex vivo, indicating that NETs can augment tumour growth in vivo. This evidence concerns the gene DNASE1 and neoplasm.